KDNY - Chinook Therapeutics Inc
IEX Last Trade
40.38
40.380 100.000%
Share volume: 0
Last Updated: Thu 10 Aug 2023 08:24:38 PM CEST
Pharmaceutical Preparation Manufacturing :
2.72%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
30%
Profitability
25%
Dept financing
20%
Liquidity
40%
Performance
34%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-18.47%
Return on assets
-5.7%
Return on sales
0%
Return on invested capital
-40.54%
Total debt ratio
64.22%
Debt ratio change over timeo
-2.84%
Current Ratio
8.99%
Quick Ratio
0%
Cash Position Ratio
3.11%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-25.87%
Return on assets
-5.51%
Return on sales
0%
Return on invested capital
-31.28%
Total debt ratio
78.22%
Debt ratio change over timeo
-3.81%
Current Ratio
8.85%
Quick Ratio
0%
Cash Position Ratio
2.99%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-35.64%
Return on assets
-5.64%
Return on sales
0%
Return on invested capital
-25.92%
Total debt ratio
82.43%
Debt ratio change over time
-6.43%
Current Ratio
8.91%
Quick Ratio
0%
Cash Position Ratio
3.5%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-42.07%
Return on assets
-84.83%
Return on sales
0%
Return on invested capital
3.66%
Total debt ratio
-283.96%
Debt ratio change over time
-2.84%
Current Ratio
-24.67%
Quick Ratio
0%
Cash Position Ratio
-9.25%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | KDNY | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -18.47% | 0% | 0% | 29.06% |
| Return on assets | -5.7% | 0% | 0% | -9.75% |
| Return on sales | 0% | 0% | 0% | -1469.44% |
| Return on invested capital | -40.54% | 0% | 0% | 47.78% |
| Profitability | 25% | 0% | 25% | 50% |
| Total debt ratio | 64.22% | 0% | 0% | 183.15% |
| Debt ratio change over time | -2.84% | 0% | 0% | 19.02% |
| Dept financing | 9% | 0% | 0% | 50% |
| Current Ratio | 8.85% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 2.99% | 0% | 0% | 5.68% |
| Liquididy | 45% | 0% | 0% | 61% |
| Short-term ratios | KDNY | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -25.87% | 0% | 0% | -16.12% |
| Return on assets | -5.51% | 0% | 0% | -14.95% |
| Return on sales | 0% | 0% | 0% | -3498.94% |
| Return on invested capital | -31.28% | 0% | 0% | 96.56% |
| Profitability | 25% | 0% | 50% | 25% |
| Total debt ratio | 78.22% | 0% | 0% | 79.61% |
| Debt ratio change over time | -3.81% | 0% | 0% | 0.09% |
| Dept financing | 25% | 0% | 0% | 50% |
| Current Ratio | 8.85% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 2.99% | 0% | 0% | 5.68% |
| Liquididy | 38% | 0% | 0% | 67% |